Latest Commercialization News

Sunstone Metals has raised $8 million through a discounted share placement to fund a scoping study and drilling at its Bramaderos Gold-Copper Project in Ecuador, while advancing strategic corporate discussions.

Anax Metals has completed a $2.4 million strategic placement with mining group Gold Valley at a 37.5% premium, while securing a $3.5 million loan to repay convertible notes, positioning the Whim Creek copper project for near-term development.

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

The Minerals Development Company Botswana has increased its investment in Botala Energy’s Serowe coal bed methane project to approximately A$4 million, signaling strong government backing for the company’s LNG ambitions.

Accelerate Resources has raised A$900,000 through a share placement to fund expanded drilling and geophysical surveys at its Balagundi Gold Project in Western Australia.

Eden Innovations has landed its largest order yet from Holcim Ecuador, signalling accelerating demand for its EdenCrete®Pz7 concrete additive and reinforcing its growth trajectory.

Kairos Minerals has signed a pivotal Mining Agreement with the Nyamal Aboriginal Corporation, marking a crucial step toward advancing the Mt York Gold Project in Western Australia's Pilbara region.

Artrya Limited has landed a significant three-year commercial agreement with Northeast Georgia Health System, marking its second U.S. customer for the AI-powered Salix platform. This deal accelerates Artrya’s footprint in cardiovascular diagnostics across a major U.S. health network.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

American Rare Earths has appointed mining veteran Mark Wall as CEO to lead its transition from exploration to production, focusing on advancing its flagship Halleck Creek project and expanding its U.S. market presence.

Imugene Limited has received positive feedback from the FDA, aligning key requirements to progress its azer-cel therapy into a pivotal clinical trial, underscoring its growing promise in blood cancer treatment.

Ovanti Limited’s US subsidiary has secured a key partnership with Mastercard’s Finicity to enhance its upcoming Flote BNPL platform, aiming to revolutionize consumer finance with real-time data insights.